|
|
 |
|
|
 |
National Call to Action on Cancer Prevention and Survivorship 2010 Workshop: Innovation in the War on Cancer
Washington, D.C.
March 15, 2010
The National Call to Action on Cancer Prevention and Survivorship Community hosted the 2010 Workshop: Innovation in the War on Cancer to engage stakeholders from all parts of the cancer community and beyond to help make cancer prevention and survivorship a national priority. The Workshop provided participants with the opportunity to discuss strategies in the areas of biomedical research, advocacy and policy that have proven successful in meeting the goals of the National Call to Action since the launch of the initiative in July 2008. The event featured the release of a new paper by Boston Healthcare Associates, Recognizing Value in Oncology Innovation, which describes the evolutionary nature of progress. Participants will also identify actionable ways to leverage innovation to advance the fight against cancer.
Richard H. Carmona, M.D., M.P.H., FACS, president of Canyon Ranch Institute, 17th Surgeon General of the United States (2002-2006) and Billy Tauzin, president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA) gave the opening keynote addresses to launch the day’s events and to encourage Workshop participants to share their best thinking toward furthering the goals and strategies of the National Call to Action. Howard Koh, M.D., M.P.H., Assistant Secretary for Health, U.S. Department of Health and Human Services presented the mid-day keynote address. Panel discussions focused on the role of innovation in biomedical research and development, advocacy, and policy in moving the initiative forward.
Panel 1: Where is the innovation happening and how?
-
Moderator: Kavita Patel, M.D., M.S.H.S, The White House
-
Thomas F. Goss, Pharm.D., Boston Healthcare Associates
-
Ruth Rechis, Ph.D., Lance Armstrong Foundation
-
Kenneth Buetow, Ph.D., National Cancer Institute
-
Laura Seeff, M.D., Centers for Disease Control and Prevention
Panel 2: How do we catalyze continued innovation in the war on cancer?
-
Moderator: Steven Patierno, Ph.D., George Washington University Cancer Institute
-
Mace Rothenberg, M.D., Pfizer
-
Kim Thiboldeaux, Cancer Support Community
-
Adam M. Clark, Ph.D., Lance Armstrong Foundation
-
Peter Greenwald, M.D., Dr.P.H., National Cancer Institute
Read more about the 2010 Workshop: Innovation in the War on Cancer:
Click here to view the Workshop agenda and speaker bios.
Click here to read the paper Recognizing Value in Oncology Innovation.
|
|